These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition. Salameh TS; Bullock KM; Hujoel IA; Niehoff ML; Wolden-Hanson T; Kim J; Morley JE; Farr SA; Banks WA J Alzheimers Dis; 2015; 47(3):715-28. PubMed ID: 26401706 [TBL] [Abstract][Full Text] [Related]
4. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. Craft S; Raman R; Chow TW; Rafii MS; Sun CK; Rissman RA; Donohue MC; Brewer JB; Jenkins C; Harless K; Gessert D; Aisen PS JAMA Neurol; 2020 Sep; 77(9):1099-1109. PubMed ID: 32568367 [TBL] [Abstract][Full Text] [Related]
5. Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease. Kellar D; Lockhart SN; Aisen P; Raman R; Rissman RA; Brewer J; Craft S J Prev Alzheimers Dis; 2021; 8(3):240-248. PubMed ID: 34101779 [TBL] [Abstract][Full Text] [Related]
6. Intranasal Insulin for Alzheimer's Disease. Hallschmid M CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428 [TBL] [Abstract][Full Text] [Related]
7. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101 [TBL] [Abstract][Full Text] [Related]
8. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments. Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944 [TBL] [Abstract][Full Text] [Related]
9. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy. Wong CYJ; Baldelli A; Hoyos CM; Tietz O; Ong HX; Traini D Drug Deliv Transl Res; 2024 Jul; 14(7):1776-1793. PubMed ID: 38441832 [TBL] [Abstract][Full Text] [Related]
10. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655 [TBL] [Abstract][Full Text] [Related]
11. Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art. de la Monte SM Expert Opin Drug Deliv; 2013 Dec; 10(12):1699-709. PubMed ID: 24215447 [TBL] [Abstract][Full Text] [Related]
12. Intranasal administration of insulin lowers amyloid-beta levels in rat model of diabetes. Subramanian S; John M Indian J Exp Biol; 2012 Jan; 50(1):41-4. PubMed ID: 22279939 [TBL] [Abstract][Full Text] [Related]
13. Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review. Avgerinos KI; Kalaitzidis G; Malli A; Kalaitzoglou D; Myserlis PG; Lioutas VA J Neurol; 2018 Jul; 265(7):1497-1510. PubMed ID: 29392460 [TBL] [Abstract][Full Text] [Related]
14. Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition. Rhea EM; Humann SR; Nirkhe S; Farr SA; Morley JE; Banks WA J Alzheimers Dis; 2017; 57(1):241-252. PubMed ID: 28222522 [TBL] [Abstract][Full Text] [Related]
15. A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease. Rosenbloom MH; Barclay TR; Pyle M; Owens BL; Cagan AB; Anderson CP; Frey WH; Hanson LR CNS Drugs; 2014 Dec; 28(12):1185-9. PubMed ID: 25373630 [TBL] [Abstract][Full Text] [Related]
16. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. Claxton A; Baker LD; Wilkinson CW; Trittschuh EH; Chapman D; Watson GS; Cholerton B; Plymate SR; Arbuckle M; Craft S J Alzheimers Dis; 2013; 35(4):789-97. PubMed ID: 23507773 [TBL] [Abstract][Full Text] [Related]
17. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. Freiherr J; Hallschmid M; Frey WH; Brünner YF; Chapman CD; Hölscher C; Craft S; De Felice FG; Benedict C CNS Drugs; 2013 Jul; 27(7):505-14. PubMed ID: 23719722 [TBL] [Abstract][Full Text] [Related]